The FTC's Criticism of “Junk” Orange Book Filings

A New Wave of Agency Challenges to Pharmaceutical Patent Holders

Since issuing the Orange Book policy statement, the FTC has embarked on two rounds of pat- ... Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs ( ...

Other Barks and Bites for Friday, May 3: FTC Adds Ozempic and 300 ...

... the FTC adds 300 drugs to the FDA's Orange Book of junk patent listings; and eight major U.S. newspapers sue OpenAI and Microsoft for ...

FTC International Monthly - October

The FTC announced a new proposed rule to prohibit junk fees, which are hidden and bogus fees that can harm consumers and undercut honest businesses. The FTC has ...

Antitrust and Competition Life Sciences Quarterly Update Q2 2024

FTC Continues to Challenge Patent Listings in FDA Orange Book ... FTC, “FTC Expands Patent Listing Challenges, Targeting More than 300 Junk ...

Submission of patent information, 21 C.F.R. § 314.53 | Casetext

... junk” Orange Book patent listingsThe new warning letters are the latest ... Orange Book, although that decision has now been stayed pending Federal Circuit review ...

FTC's watchdog role in pharma mergers: Road bumps and the way ...

The FTC labeled the contested patents as “junk” patents, claiming that these ... Her analysis of 17 FTC enforcement cases related to pharmaceutical ...

24-1936 Document: 62 Page: 1 Filed: 09/06/2024 - Fed Circuit Blog -

Teva has violated the FTC Act through improper Orange Book listings ... Targeting More Than 300 Junk Listings for Diabetes, Weight Loss,.

Months In Brief Archive - Business Law Today from ABA

... Junk Fees as FTC Proposes Junk Fee Ban, California Passes Junk Fee Legislation ... Orange Book May Be Considered a Violation of the FTC Act. By Michael ...

Keyword: orange book - NAVLIN DAILY

FTC to Challenge Additional “Junk” Patents, Including Listings for Ozempic ... The U.S. Federal Trade Commission (FTC) filed an amicus brief related to the ...

Jacqueline Grise - Ropes & Gray LLP - Experts - Lexology

The FTC's Criticism of “Junk” Orange Book Filings: The Latest Squall in a Regulatory Rainstorm. 27 May 2024. Seizing yet another arrow in the Biden ...

FTC crackdown on 'bogus' patents hits Novo's Ozempic, GSK's ...

The crackdown, which comes six months after FTC challenged 10 pharma majors in a similar fashion, targets so-called “junk” patents — listings ...

Docket No. PTO-P-2023-0048 Patent Trial and ... - Regulations.gov

... ftc-challenges-more-100-patents-improperly-listed- fdas-orange-book; FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes,.

Analyses of Section 314.3 - Definitions, 21 C.F.R. § 314.3 | Casetext

us” and “junk” Orange Book patent listingsThe new warning letters are the ... The letters informed the companies that the FTC was disputing certain of their ...

The FTC is Holding Corporate America Accountable: Protecting ...

Banned car dealerships from using junk fees and unfair bait-and-switch tactics to ... listings on asthma inhalers from the FDA's Orange Book, ...

Biden's FTC took on big tech, big pharma and more. What antitrust ...

... President Joe Biden announces his administration's plans to eliminate junk fees for consumers, Wednesday, Oct.

Teva secures stay on Orange Book inhaler patent delisting

'Every CMS filing is painful': Notes from a Unified Patent Court dispute. 26 September 2024. Unified Patent Court · Interview: Klaus Grabinski ...